If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yasuo Hamamoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 4067 Citations
  • 27 h-Index
  • 92 Article
  • 6 Review article
  • 3 Letter
  • 2 Comment/debate

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

Yokota, T., Kato, K., Hamamoto, Y., Tsubosa, Y., Ogawa, H., Ito, Y., Hara, H., Ura, T., Kojima, T., Chin, K., Hironaka, S., Kii, T., Kojima, Y., Akutsu, Y., Matsushita, H., Kawakami, K., Mori, K., Makiuchi, T., Nagumo, R. & Kitagawa, Y., 2020 Feb 1, In : Annals of Surgical Oncology. 27, 2, p. 460-467 8 p.

Research output: Contribution to journalArticle

  • 3 Citations (Scopus)

    Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites

    Hamamoto, Y., Piao, Y. & Makiyama, A., 2020 May 1, In : Gastric Cancer. 23, 3, p. 363-372 10 p.

    Research output: Contribution to journalReview article

    Open Access
  • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

    Chen, L. T., Satoh, T., Ryu, M. H., Chao, Y., Kato, K., Chung, H. C., Chen, J. S., Muro, K., Kang, W. K., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L. Y., Tamura, T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., Minashi, K. & 5 others, Cho, J. Y., Tsuda, M., Sameshima, H., Kang, Y. K. & Boku, N., 2020 May 1, In : Gastric Cancer. 23, 3, p. 510-519 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Citations (Scopus)

    A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure–Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)

    Suzuki, T., Sukawa, Y., Imamura, C. K., Masuishi, T., Satake, H., Kumekawa, Y., Funakoshi, S., Kotaka, M., Horie, Y., Kawai, S., Okuda, H., Terazawa, T., Kondoh, C., Kato, K., Yoshimura, K., Ishikawa, H., Hamamoto, Y., Boku, N., Takaishi, H. & Kanai, T., 2020 Mar, In : Clinical Colorectal Cancer. 19, 1, p. 13-21.e3

    Research output: Contribution to journalArticle

  • Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

    Satoh, T., Kang, Y. K., Chao, Y., Ryu, M. H., Kato, K., Cheol Chung, H., Chen, J. S., Muro, K., Ki Kang, W., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L. Y., Tamura, T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., Minashi, K. & 5 others, Cho, J. Y., Tsuda, M., Tanimoto, M., Chen, L. T. & Boku, N., 2020 Jan 1, In : Gastric Cancer. 23, 1, p. 143-153 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Citations (Scopus)